Literature DB >> 10531251

Shiga toxin-producing Escherichia coli can impair T84 cell structure and function without inducing attaching/effacing lesions.

Z Li1, E Elliott, J Payne, J Isaacs, P Gunning, E V O'loughlin.   

Abstract

Enteropathogenic Escherichia coli (EPEC) intimately adhere to epithelial cells producing cytoskeletal rearrangement with typical attaching and effacing lesions and altered epithelial barrier and transport function. Since EPEC and Shiga toxin-producing E. coli (STEC) share similar genes in the "locus for enterocyte effacement" (LEE) thought to cause these changes, it has been assumed that STEC shares similar pathogenic mechanisms with EPEC. The aims of this study were to compare the effects of EPEC and STEC on bacterial-epithelial interactions and to examine changes in epithelial function. T84 monolayers were infected with STEC O157:H7 (wild strain EDL 933 or non-toxin-producing strain 85/170), EPEC (strain E2348/69), or HB101 (nonpathogenic) and studied at various times after infection. EPEC bound more avidly than EDL 933, but both strains exhibited greater binding than HB101. Attaching and effacing lesions and severe disruption to the actin cytoskeleton were observed in EPEC by 3 h postinfection but not in EDL 933 or HB101 at any time point. EPEC and EDL 933 increased monolayer permeability to [(3)H]mannitol 5- to 10-fold. In contrast to EPEC, EDL 933 completely abolished secretagogue-stimulated anion secretion as assessed under voltage clamp conditions in Ussing chambers. Several other STEC strains induced changes similar to those of EDL 933. In conclusion, STEC impairs epithelial barrier function and ion transport without causing major disruption to the actin cytoskeleton. Pathogenic factors other than products of LEE may be operant in STEC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531251      PMCID: PMC96977     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Stabilization of F-actin prevents cAMP-elicited Cl- secretion in T84 cells.

Authors:  M Shapiro; J Matthews; G Hecht; C Delp; J L Madara
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  In vivo evidence of altered chloride but not potassium secretion in cystic fibrosis rectal mucosa.

Authors:  J L Goldstein; A B Shapiro; M C Rao; T J Layden
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

3.  Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets.

Authors:  S Tzipori; H Karch; K I Wachsmuth; R M Robins-Browne; A D O'Brien; H Lior; M L Cohen; J Smithers; M M Levine
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

4.  Electrolyte transport in rabbit cecum. I. Effect of RDEC-1 infection.

Authors:  Y H Tai; T P Gage; C McQueen; S B Formal; E C Boedeker
Journal:  Am J Physiol       Date:  1989-04

5.  Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases.

Authors:  P M Griffin; L C Olmstead; R E Petras
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

6.  Abnormal epithelial transport in cystic fibrosis jejunum.

Authors:  E V O'Loughlin; D M Hunt; K J Gaskin; D Stiel; I M Bruzuszcak; H C Martin; C Bambach; R Smith
Journal:  Am J Physiol       Date:  1991-05

7.  Adherence of enterohemorrhagic Escherichia coli strains to a human colonic epithelial cell line (T84).

Authors:  D K Winsor; S Ashkenazi; R Chiovetti; T G Cleary
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Translocated intimin receptors (Tir) of Shiga-toxigenic Escherichia coli isolates belonging to serogroups O26, O111, and O157 react with sera from patients with hemolytic-uremic syndrome and exhibit marked sequence heterogeneity.

Authors:  A W Paton; P A Manning; M C Woodrow; J C Paton
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

10.  Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S Knutton; T Baldwin; P H Williams; A S McNeish
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

View more
  12 in total

1.  Do eicosanoids cause colonic dysfunction in experimental E coli O157:H7 (EHEC) infection?

Authors:  C J Bell; E J Elliott; J L Wallace; D M Redmond; J Payne; Z Li; E V O'Loughlin
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration.

Authors:  B P Hurley; C M Thorpe; D W Acheson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 3.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

4.  Afa/Dr diffusely adhering Escherichia coli C1845 infection promotes selective injuries in the junctional domain of polarized human intestinal Caco-2/TC7 cells.

Authors:  I Peiffer; A B Blanc-Potard; M F Bernet-Camard; J Guignot; A Barbat; A L Servin
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Escherichia coli heat-stable toxin b impairs intestinal epithelial barrier function by altering tight junction proteins.

Authors:  Clément Ngendahayo Mukiza; J Daniel Dubreuil
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

6.  Polarization of specific tropomyosin isoforms in gastrointestinal epithelial cells and their impact on CFTR at the apical surface.

Authors:  Jacqueline Rae Dalby-Payne; Edward Vincent O'Loughlin; Peter Gunning
Journal:  Mol Biol Cell       Date:  2003-09-05       Impact factor: 4.138

7.  Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.

Authors:  V K Viswanathan; Athanasia Koutsouris; Sandra Lukic; Mark Pilkinton; Ivana Simonovic; Miljan Simonovic; Gail Hecht
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

8.  Intimin, tir, and shiga toxin 1 do not influence enteropathogenic responses to shiga toxin-producing Escherichia coli in bovine ligated intestinal loops.

Authors:  Mark P Stevens; Olivier Marchès; June Campbell; Veronika Huter; Gad Frankel; Alan D Phillips; Eric Oswald; Timothy S Wallis
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

9.  In vitro adhesion properties of Shiga toxin-producing Escherichia coli isolated from cattle, food, and humans.

Authors:  Nathalie Pradel; Lucie Etienne-Mesmin; Jonathan Thévenot; Charlotte Cordonnier; Stéphanie Blanquet-Diot; Valérie Livrelli
Journal:  Front Microbiol       Date:  2015-02-27       Impact factor: 5.640

10.  Enterohemorrhagic Escherichia coli colonization of human colonic epithelium in vitro and ex vivo.

Authors:  Steven B Lewis; Vivienne Cook; Richard Tighe; Stephanie Schüller
Journal:  Infect Immun       Date:  2014-12-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.